Literature DB >> 7665861

Molecular analysis of intraspousal transmission of hepatitis C virus.

K Chayama1, M Kobayashi, A Tsubota, I Koida, Y Arase, S Saitoh, K Ikeda, H Kumada.   

Abstract

BACKGROUND/AIMS: Although intraspousal transmission of hepatitis C virus (HCV) has been speculated, there is no direct evidence.
METHODS: To investigate whether transmission of HCV occurs by this route, 295 spouses of persons diagnosed with HCV were studied. Of these, 25 (8.8%) tested positive for anti-HCV. Next, the HCV genotype was determined by polymerase chain reaction using a mixed primer set, and cDNA was obtained in 17 of the 25 couples for comparison of the genotypes.
RESULTS: Of these 17, 14 (82.4%) spouses were shown to be infected with HCV of the same genotype. Analysis of the nucleotide sequences of putative E1 gene of eight couples having the same HCV genotype revealed that five couples had remarkably high nucleotide sequence homologies (> 97%), whereas samples obtained from the remaining three couples showed relatively low homology (91-92%). Nucleotide sequence homologies were significantly higher between spouses than between non-spouse pairs of isolates. Phylogenetic analysis using the neighbor-joining method suggests that infection in these five couples probably occurred after marriage. Furthermore, none of the five couples had shared other possible transmission routes such as intravenous drug use, dental treatment or acupuncture.
CONCLUSION: These data strongly suggest the occurrence of intraspousal transmission of HCV.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7665861     DOI: 10.1016/0168-8278(95)80106-5

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  14 in total

1.  Clinical guidelines on the management of hepatitis C.

Authors:  J C Booth; J O'Grady; J Neuberger
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

Review 2.  Hepatitis C virus infection in the elderly. Epidemiology, prophylaxis and optimal treatment.

Authors:  J Hayashi; S Kashiwagi
Journal:  Drugs Aging       Date:  1997-10       Impact factor: 3.923

3.  HCV transmission in family members of subjects with HCV related chronic liver disease.

Authors:  L Demelia; E Vallebona; R Poma; G Sanna; G Masia; R C Coppola
Journal:  Eur J Epidemiol       Date:  1996-02       Impact factor: 8.082

4.  Lack of evidence of sexual transmission of hepatitis C virus in a prospective cohort study of men who have sex with men.

Authors:  Michel Alary; Jean R Joly; Jean Vincelette; René Lavoie; Bruno Turmel; Robert S Remis
Journal:  Am J Public Health       Date:  2005-03       Impact factor: 9.308

5.  Molecular evidence of male-to-female sexual transmission of hepatitis C virus after vaginal and anal intercourse.

Authors:  P Halfon; H Riflet; C Renou; Y Quentin; P Cacoub
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

6.  Heterosexual transmission of GB virus C/hepatitis G virus infection to non-intravenous drug-using female prostitutes in Fukuoka, Japan.

Authors:  Y Sawayama; J Hayashi; Y Etoh; H Urabe; K Minami; S Kashiwagi
Journal:  Dig Dis Sci       Date:  1999-10       Impact factor: 3.199

Review 7.  Update on chronic viral hepatitis.

Authors:  K Walsh; G J Alexander
Journal:  Postgrad Med J       Date:  2001-08       Impact factor: 2.401

8.  The management of chronic hepatitis C virus infection.

Authors:  J C Booth; J L Brown; H C Thomas
Journal:  Gut       Date:  1995-10       Impact factor: 23.059

9.  Prevalence of hepatitis C infection in a population of asymptomatic people in a checkup unit in Mexico city.

Authors:  Nahum Méndez-Sánchez; Guadalupe Ponciano-Rodriguez; Norberto C Chávez-Tapia; Daniel Motola-Kuba; Paloma Almeda-Valdes; Karla Sánchez-Lara; Martha H Ramos; Misael Uribe
Journal:  Dig Dis Sci       Date:  2005-04       Impact factor: 3.199

Review 10.  Managing occupational risks for hepatitis C transmission in the health care setting.

Authors:  David K Henderson
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.